Capio’s application for de-listing approved

Capio AB (publ) (“Capio”) has, as previously announced, applied for de-listing of Capio’s shares from Nasdaq Stockholm. Nasdaq Stockholm has now approved the application and decided that the last day of trading will be 28 November 2018.

For information, please contact:
Henrik Brehmer, SVP Group Communication & Public Affairs
Telephone: +46 761 11 34 14

Capio AB (publ) is a leading, pan-European healthcare provider offering a broad range of high quality medical, surgical and psychiatric healthcare services through its hospitals, specialist clinics and primary care units. Capio operates in five countries; Sweden, Norway, Denmark, France and Germany. In 2017, Capio’s 13,314 employees (average full-time equivalents) provided healthcare services during 5.1 million patient visits across the Group’s facilities, generating net sales of MSEK 15,327. Capio operates across three geographic segments: Nordic (57% of Group net sales 2017), France (35% of Group net sales 2017) and Germany (8% of Group net sales 2017). For more information about Capio, please see www.capio.com.

About Us

Capio is offering a broad range of high quality medical, surgical and psychiatric healthcare services through its hospitals, specialist clinics and primary care units in Sweden, Norway, Denmark, France and Germany. Since November 2018, Capio is part of Ramsay Générale de Santé, creating a leading provider of healthcare services in Europe with combined net sales of EUR 3.8 billion and approximately 36,000 employees. For more information about Capio and Ramsay Générale de Santé, please see www.capio.com and www.ramsaygds.fr.

Subscribe

Documents & Links